| 中文名称: | L-高胱氨酸硫内酯盐酸盐 | 中文别名: | L-高胱氨酸硫内酯盐酸盐 |
|---|---|---|---|
| 英文名称: | L-Homocysteine Thiolactone Hydrochloride | CAS: | 31828-68-9 |
| 产品分类: | 小分子化合物 | 纯度: | ≥98% |
| 产品编号 | 品牌 | 纯度 | 规格 | 库存 | 价格 |
|---|---|---|---|---|---|
| IH2880 | 索莱宝 | ≥98% | 100mg | 有现货 | 936.00 元 |
| IH2880 | 索莱宝 | ≥98% | 10mg | 有现货 | 230.00 元 |
| IH2880 | 索莱宝 | ≥98% | 25mg | 有现货 | 470.00 元 |
| IH2880 | 索莱宝 | ≥98% | 50mg | 有现货 | 774.00 元 |
| 标准名称: | 高半胱氨酸硫内酯 | 英文名称: | L-Homocysteine thiolactone hydrochloride |
|---|---|---|---|
| CAS: | 31828-68-9 | 分子式: | C4H8ClNOS |
| 分子量: | 153.630418777466 | 颜色与性状: | 固体 |
| 密度: | 沸点: | 253.8°C at 760 mmHg | |
| 熔点: | 165-166 ºC | 水溶性: |
| CAS | 31828-68-9 |
| 中文名称 | L-高胱氨酸硫内酯盐酸盐 |
| 英文名称 | L-Homocysteine Thiolactone Hydrochloride |
| 分子式 | C4H8ClNOS |
| 分子量 | 153.63 |
| 规格 | 100mg ; 10mg ; 25mg ; 50mg |
| 溶解性 | Soluble in Water ≥2mg/mL |
| 纯度 | ≥98% |
| 级别 | Cell Culture |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| 运输条件 | 冷藏运输 |
| EC | EINECS 250-824-1 |
| MDL | MFCD00065494 |
| SMILES | C1CSC(=O)C1N.Cl |
| InChIKey | ZSEGSUBKDDEALH-DFWYDOINSA-N |
| InChI | InChI=1S/C4H7NOS.ClH/c5-3-1-2-7-4(3)6;/h3H,1-2,5H2;1H/t3-;/m0./s1 |
| PubChem CID | 10313226 |
| Beilstein Number | 3911460 |
| 靶点 | Others |
| 通路 | Others |
| 背景说明 | 是一种化合物,具有多种生物学或化学活性。 |
| 生物活性 | L-Homocysteine thiolactone hydrochloride is an intramolecular thioester of homocysteine; prevents translational incorporation of homocysteine into proteins.[1-5] |
| In Vitro | In all cell types, from bacterial to human, homocysteine is metabolized to homocysteine thiolactone by methionyl-tRNA synthetase. Elevated levels of homocysteine are an independent risk factor for cardiovascular disease in humans. Homocysteine can be harmful to human cells because of its metabolic conversion to homocysteine thiolactone, a reactive thioester. This conversion occurs in all human cell types, including endothelial cells[1]. Homocysteine thiolactone induces cell death and features of apoptosis including increased phosphotidylserine exposure on the membrane surface, increased apoptotic cells with hypoploid DNA contents, and internucleosomal DNA fragmentation in HL-60 cells[2]. Homocysteine thiolactone is cytotoxic and capable of promoting cell death, as measured by caspase-3 activation and DNA fragmentation. HcyT strongly activates IL-8 release[3]. |
| In Vivo | Homocysteine thiolactone is toxic, induces epileptic seizures in rodents, and has been implicated in Alzheimer’s disease[4]. Homocysteine thiolactone induces two types of seizures, the coexistence of convulsive and nonconvulsive epilepsy. The grade of seizures is dose dependent[5]. |
| 细胞实验 | HUVEC are treated with homocysteine (1, 5, 10 mM) or homocysteine thiolactone (0.25, 0.5, 1 mM) for 3, 6, 12 and 24 h. Cell survival is determined by the MTT method. The optical density is measured at 570 nm with 630 nm as a reference[3]. |
| 动物实验 | Rats: Homocysteine thiolactone is freshly prepared in saline and administered in a volume of 1.0 mL/100 g body weight. Rats are divided into control (saline-injected) group and homocysteine thiolactone-treated group. The latter group receives different doses 5.5 mM/kg, 8.0 mM/kg, and 11.0 mM/kg, respectively. Each rat is used only once[5]. |
| 数据来源文献 | [1]. Jakubowski H, et al. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr. 2000 Feb;130(2S Suppl):377S-381S. [2]. Huang RF, et al. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellularhydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci. 2001 May 11;68(25):2799-811. [3]. Kerkeni M, et al. Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVECcells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone. Mol Cell Biochem. 2006 Oct;291(1-2):119-26. [4]. Borowczyk K, et al. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1. J Alzheimers Dis. 2012;30(2):225-31. [5]. Stanojlovi? O, et al. Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study. Cell Mol Neurobiol. 2009 May;29(3):329-39. |
| 单位 | 瓶 |
| 1mM-5mg | 32.5457mL |
| 1mM-1mg | 6.5091mL |
| 1mM-10mg | 65.0915mL |
| 5mM-1mg | 1.3018mL |
| 5mM-5mg | 6.5091mL |
| 5mM-10mg | 13.0183mL |
| 10mM-1mg | 0.6509mL |
| 10mM-5mg | 3.2546mL |
| 10mM-10mg | 6.5091mL |
公司拥有一批专业的研发人员,我们专注于生物产品的不断完善和创新。产品覆盖面广,品质可靠。先后开发了涵盖分子生物学、细胞生物学、免疫学、生物医学等领域的多种试剂及试剂盒。同时,索莱宝公司提供各种常规生化试剂,库存常备产品多达10000多种,可随时为广大科研工作者提供各类专业试剂。在质量方面,索莱宝谨记公司信念:质量高于一切。所有研发的产品都设有严谨的生产流程,科学的质量检测方法和成熟的质量检测程序,我们恪守对每一位用户的承诺:用专业的态度做专业的品牌。同时,公司组建了一支专业的技术服务队伍,能够为科研工作者提供专业的技术服务。每一位购买索莱宝产品的用户都能够得到专业的咨询和完善的售后服务。
索莱宝公司坚持与国际接轨,注重和国际先进企业的合作与交流,并提供产品代理、市场咨询等多项服务。公司将一如既往与世界更多知名品牌合作,不断为广大生物科研工作者提供更优质的产品和服务。公司理念:“为科研服务,为生命尽责”。一个人能够走多远,取决于与谁同行。索莱宝公司期待与各同行精诚合作。
索莱宝诚招生物试剂研发人员,期待与广大同行精诚合作,为广大科研工作者提供优质的产品,高效的物流以及专业的售后服务。索莱宝感谢所有朋友的支持与帮助,您的支持是我们前进的动力和保障。让我们携手同行,共同创造美好的明天。
| 企业认证: | 已认证 | 企业性质: | 生产研发 |
|---|---|---|---|
| 主营产品: | 3-羟基苯乙酸 ; 1-氨基-1-环己基甲酸 ; 阿奇霉素 ; 甲磺酸达氟沙星 ; CY7-N-羟基琥珀酰胺酯 三乙胺盐 ; | 供货范围: | 试剂 |
| 产品目录: | 119719 | 品牌: | 索莱宝 |
| 纯度 | 品牌 | 规格 | 发货地 |
|---|---|---|---|
| 98.00% | 索莱宝 | 5g / 10g / 25g / 100g | 北京 |